1. Home
  2. SLGN vs IMVT Comparison

SLGN vs IMVT Comparison

Compare SLGN & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silgan Holdings Inc.

SLGN

Silgan Holdings Inc.

HOLD

Current Price

$41.28

Market Cap

4.2B

Sector

Industrials

ML Signal

HOLD

Logo Immunovant Inc.

IMVT

Immunovant Inc.

HOLD

Current Price

$24.55

Market Cap

5.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLGN
IMVT
Founded
1987
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
5.0B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
SLGN
IMVT
Price
$41.28
$24.55
Analyst Decision
Strong Buy
Buy
Analyst Count
9
9
Target Price
$52.78
$30.78
AVG Volume (30 Days)
752.3K
1.2M
Earning Date
04-29-2026
05-28-2026
Dividend Yield
1.91%
N/A
EPS Growth
4.65
N/A
EPS
2.70
N/A
Revenue
$4,489,927,000.00
N/A
Revenue This Year
$4.83
N/A
Revenue Next Year
$2.13
N/A
P/E Ratio
$15.46
N/A
Revenue Growth
0.92
N/A
52 Week Low
$36.15
$13.36
52 Week High
$57.04
$29.25

Technical Indicators

Market Signals
Indicator
SLGN
IMVT
Relative Strength Index (RSI) 51.01 47.09
Support Level $37.10 $22.25
Resistance Level $41.79 $25.32
Average True Range (ATR) 0.94 1.25
MACD 0.52 0.13
Stochastic Oscillator 81.49 51.69

Price Performance

Historical Comparison
SLGN
IMVT

About SLGN Silgan Holdings Inc.

Silgan Holdings Inc is a manufacturer of sustainable rigid packaging solutions for the world's essential consumer goods products. Its products include: dispensing and specialty closures for fragrance and beauty, food, beverage, personal and health care, home care and lawn and garden products; steel and aluminum containers for pet and human food and general line products; and custom designed plastic containers for pet and human food, consumer health and pharmaceutical, personal care, home care, lawn and garden and automotive products.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

Share on Social Networks: